Detalhe da pesquisa
1.
Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease.
Nat Immunol
; 15(8): 767-76, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24973820
2.
Regulation of lymphoid-myeloid lineage bias through regnase-1/3-mediated control of Nfkbiz.
Blood
; 143(3): 243-257, 2024 Jan 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37922454
3.
The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development.
Immunity
; 46(5): 818-834.e4, 2017 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-28514688
4.
Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate.
Nat Immunol
; 13(12): 1196-204, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23064439
5.
The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells.
Nat Immunol
; 12(10): 992-1001, 2011 Aug 21.
Artigo
Inglês
| MEDLINE | ID: mdl-21857655
6.
The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.
Genes Dev
; 29(4): 409-25, 2015 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25691468
7.
ß-Selection-induced proliferation is required for αß T cell differentiation.
Immunity
; 37(5): 840-53, 2012 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-23159226
8.
4-Pyridone-3-carboxylic acid as a benzoic acid bioisostere: Design, synthesis, and evaluation of EP300/CBP histone acetyltransferase inhibitors.
Bioorg Med Chem Lett
; 51: 128358, 2021 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34534674
9.
The Evolution of Rag Gene Enhancers and Transcription Factor E and Id Proteins in the Adaptive Immune System.
Int J Mol Sci
; 22(11)2021 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34072618
10.
Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.
Biochem Biophys Res Commun
; 526(1): 128-134, 2020 05 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32199616
11.
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Lancet Oncol
; 20(5): 625-635, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30975627
12.
Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial.
J Med Internet Res
; 21(4): e13520, 2019 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-30982776
13.
Regional differences in the prevalence of sensitization to environmental allergens: Analysis on IgE antibody testing conducted at major clinical testing laboratories throughout Japan from 2002 to 2011.
Allergol Int
; 68(4): 440-449, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31036486
14.
[Analysis of Post-Recurrence Survival of Resected Lung Cancer with Brain Metastasis].
Gan To Kagaku Ryoho
; 46(13): 2276-2278, 2019 Dec.
Artigo
Japonês
| MEDLINE | ID: mdl-32156903
15.
[Four Cases of Resected cN2 Stage III A Non-Small-Cell Lung Cancer after Induction Chemotherapy].
Gan To Kagaku Ryoho
; 45(4): 673-675, 2018 Apr.
Artigo
Japonês
| MEDLINE | ID: mdl-29650831
16.
The establishment of B versus T cell identity.
Trends Immunol
; 35(5): 205-10, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24679436
17.
[Long-Term Local Control with Radiofrequency Ablation or Radiotherapy for Second, Third, and Fourth Lung Tumors after Lobectomy for Primary Lung Cancer].
Gan To Kagaku Ryoho
; 43(12): 2416-2418, 2016 Nov.
Artigo
Japonês
| MEDLINE | ID: mdl-28133340
18.
Evaluation of cigarette smoke-induced emphysema in mice using quantitative micro-computed tomography.
Am J Physiol Lung Cell Mol Physiol
; 308(10): L1039-45, 2015 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25820526
19.
Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.
Cancer Sci
; 106(6): 734-739, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25786335
20.
Discovery of DS-5272 as a promising candidate: A potent and orally active p53-MDM2 interaction inhibitor.
Bioorg Med Chem
; 23(10): 2360-7, 2015 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25882531